Emicizumab Biosimilar（Anti-F9 / Factor IX Reference Antibody） Datasheet DC Chemicals
Description Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research.
Cat.No A090
Name Emicizumab Biosimilar（Anti-F9 / Factor IX Reference Antibody）

Chemical Properties

CAS 1610943-06-0
Synonyms Emicizumab;Research Grade Emicizumab (DHB87901);Emicizumab (anti-Factor IX);Emicizumab (anti-Factor IX);Emicizumab (anti-Factor IX);ACE 910|||RO 5534262;ACE 910|||RO 5534262;ACE 910|||RO 5534262
pH value Corresponds to reference standard: PASS
Non-reduced CE-SDS >95%
SEC-HPLC >95%
Isoelectric Point Corresponds to reference standard Corresponds to reference standard: PASS
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality Corresponds to reference standard: PASS
Peptide mapping Corresponds to reference standard: PASS
N-terminal sequence Corresponds to reference standard: PASS

References

Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com